Profile
Ms. Lani Ibarra is a Senior VP-Clinical Development Operations at Structure Therapeutics, Inc. Ms. Ibarra was previously employed as a Vice President-Clinical Operations by Dynavax Technologies Corp., a Vice President-Global Clinical Operations by Molecular Partners AG, and a Vice President-Global Clinical Operations by Molecular Partners, Inc. She received her undergraduate degree from the University of California, Berkeley and a graduate degree from Stanford University.
Lani Ibarra active positions
| Companies | Position | Start |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Lani Ibarra
| Companies | Position | End |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | - |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Corporate Officer/Principal | - |
| DYNAVAX TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | - |
Training of Lani Ibarra
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
- Stock Market
- Insiders
- Lani Ibarra
















